Ibugard

Ibuprofen, the active ingredient in Ibugard, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a suppository for rectal use. It provides analgesic, antipyretic and anti‑inflammatory effects for the relief of mild to moderate pain, fever and inflammatory conditions, especially when oral administration is not feasible.\n\nGNH India supplies Ibugard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring consistent quality and regulatory compliance across markets.

Ibuprofen acts systemically to reduce prostaglandin‑mediated inflammation, providing relief in several common conditions.\n\n- Pain: alleviates mild to moderate acute pain such as headache, dental pain, musculoskeletal discomfort.\n- Fever: reduces elevated body temperature associated with infections or inflammatory states.\n- Inflammation: diminishes swelling and tenderness in minor sprains, strains and soft‑tissue injuries.

Rectal ibuprofen may cause a range of adverse reactions, varying from mild to serious.\n\nCommon Side Effects:\n- Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.\n- Local irritation: burning or itching at the insertion site.\n- Headache: mild tension‑type headache.\n- Dizziness: transient light‑headedness.\n\nSerious or Rare Side Effects:\n- Gastrointestinal bleeding: ulceration or hemorrhage.\n- Renal impairment: reduced kidney function or acute renal failure.\n- Allergic reactions: rash, angio‑edema or anaphylaxis.\n- Cardiovascular events: increased risk of heart attack or stroke.

Before using Ibugard, consider the following precautions to ensure safe use.\n\n- Assess renal function: avoid use in patients with severe kidney disease.\n- Monitor gastrointestinal risk: use with caution in individuals with ulcer history.\n- Evaluate cardiovascular status: consider risk in patients with heart disease.\n- Use in pregnancy only if clearly needed: limited data for rectal ibuprofen.\n- Avoid in children under 6 months unless directed: dosing not established.\n- Store at room temperature: keep in original packaging, protect from moisture and heat.

Ibuprofen can interact with several medicines; awareness helps prevent adverse outcomes.\n\nMajor Interactions (Avoid):\n- Anticoagulants (e.g., warfarin): increased bleeding risk.\n- Other NSAIDs or aspirin: heightened gastrointestinal toxicity.\n- SSRIs: potential for bleeding.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may affect renal function.\n- Lithium: ibuprofen can raise lithium concentrations.\n- Methotrexate: risk of increased toxicity.